TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹14,396 Cr | ₹14,505 Cr | ₹14,468 Cr | ₹12,606 Cr | ₹13,653 Cr |
What is the latest Total Liabilities ratio of TORRENT PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹14,396 Cr |
Mar2024 | ₹14,505 Cr |
Mar2023 | ₹14,468 Cr |
Mar2022 | ₹12,606 Cr |
Mar2021 | ₹13,653 Cr |
How is Total Liabilities of TORRENT PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹14,396 Cr | -0.76 | |
Mar2024 | ₹14,505 Cr | 0.26 | |
Mar2023 | ₹14,468 Cr | 14.77 | |
Mar2022 | ₹12,606 Cr | -7.67 | |
Mar2021 | ₹13,653 Cr | - |
Compare Total Liabilities of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹120,683.6 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
CIPLA | ₹127,124.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics | |
MANKIND PHARMA | ₹106,486.0 Cr | 0.1% | 6.1% | 6.2% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -1.2% |
-1.7% |
4.5% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses